The deadline for Guidant Corp. to respond to Boston Scientific Corp.'s latest $25 billion buyout offer came and went on Friday, increasing the tension in the fast-paced bidding war with Johnson & Johnson for the medical device maker.
The deadline for Guidant Corp. to respond to Boston Scientific Corp.'s latest $25 billion buyout offer came and went on Friday, increasing the tension in the fast-paced bidding war with Johnson & Johnson for the medical device maker.